MediraRx
MediraRx is a New York-based 340B program administrator that provides cloud-based management software, consulting, and TPA services to safety net healthcare providers—including HIV clinics, hospitals, and health centers—helping them maximize 340B revenue and maintain regulatory compliance.
- Company typePrivate
- Founded2009
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What MediraRx does
MediraRx, founded in 2009 and headquartered in New York, is a private healthcare technology and services company that administers the federal 340B Drug Pricing Program on behalf of safety net providers. The firm delivers a cloud-based management platform combined with consulting and third-party administrator (TPA) services, helping covered entities establish, maintain, and optimize participation in 340B. Core platform capabilities include real-time compliance monitoring, patient eligibility validation, drug diversion prevention, inventory management and replenishment with NDC-specific reporting, duplicate discount prevention, contract pharmacy integration, and auditable reporting aligned with HRSA requirements. The platform is HIPAA-compliant, delivered through a 24/7 web portal, and designed to interoperate with contract pharmacies and drug wholesalers.
The product portfolio centers on the MediraRx 340B Management Platform and Software Solution, supplemented by four add-on offerings: 340B Consulting (audit support, system reviews, policy customization, and annual audit assistance), 340B TPA Services (invoice price verification, NDC reporting, and client portal access), an Advanced Referral Program for claims capture, and a Telehealth PrEP service extending into HIV prevention delivery for uninsured patients in rural and underserved areas. Together these modules allow MediraRx to address the full lifecycle of a 340B program from design and registration through ongoing compliance and revenue optimization.
MediraRx operates a sales-led, consultative go-to-market model. Dedicated account managers and a "Request a Free Consult" call-to-action drive direct engagement with target buyers, supported by content marketing, webinars, and a client referral program. The company serves HIV/AIDS clinics and service organizations, safety net hospitals, federally qualified health centers, behavioral health organizations, and STD clinics, with active engagements across more than 14 U.S. states. Pricing is quote-based and not publicly disclosed. The firm is founder-led (Ira L., Founder and CEO) and operates with 1-10 employees, indicating a small, specialized organization with no disclosed institutional funding, M&A activity, or named strategic partnerships.
MediraRx firmographics
Firmographics- Name
- MediraRx
- Website
- https://medirarx.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MediraRx is a New York-based 340B program administrator that provides cloud-based management software, consulting, and TPA services to safety net healthcare providers—including HIV clinics, hospitals, and health centers—helping them maximize 340B revenue and maintain regulatory compliance.
- Ownership category
- akta.pro rank
MediraRx industry classification
Industry- Product category
- 340B Program Management Software
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN)
Keywords
Where MediraRx is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MediraRx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- 340B Program Administration Services: MediraRx generates revenue through professional services and managed services for 340B program administration. The company provides comprehensive 340B management including consulting, software solutions, and third-party administrator (TPA) services to covered entities. Revenue is generated through service fees for program design, implementation, compliance management, reporting, and ongoing support for 340B program optimization.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
MediraRx product offering
Product offeringCore offering
MediraRx designs, implements, and manages 340B Drug Pricing Programs for safety net healthcare providers (covered entities) such as hospitals, health centers, HIV/AIDS clinics, STD clinics, and behavioral health organizations. The company combines a cloud-based 340B compliance and management software platform with third-party administrator (TPA) services, consulting, pharmacy network development, and reporting, enabling clients to maintain regulatory compliance, prevent duplicate discounts, and capture savings on outpatient drug purchases.
Product overview
MediraRx offers a cloud-based software platform and suite of services for managing the federal 340B Drug Pricing Program. The core offering consists of the MediraRx 340B Management Platform and Software Solution, which provides comprehensive end-to-end management including compliance tracking, inventory management, pharmacy integration, and real-time reporting. This core platform is supplemented by four add-on modules: 340B Consulting (audit support and compliance services), 340B TPA Services (third-party administration including inventory and invoice verification), the Advanced Referral Program (claims capture enhancement), and Telehealth PrEP (HIV prevention telehealth services). Together, these offerings enable safety net providers to maximize their 340B program revenue while maintaining regulatory compliance.
Differentiator
Problem solved
Functional benefit
Products and services
- 340B Software Solution (MediraRx 340B Management Platform)
- 340B Consulting
- 340B Third Party Administrator (TPA) Services
- 340B Advanced Referral Program
- Telehealth PrEP
Quantifiable outcome
- Hundreds of millions of dollars in revenue generated for clients through 340B program management
- +2 more outcomes
Companies that use MediraRx
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles3 records
MediraRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
MediraRx partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
MediraRx competitors and assessment
Company assessmentDirect peers
- Nuvem: Provides 340B TPA, analytics, and revenue-optimization technology for covered entities and pharmacies, directly comparable to MediraRx's platform and services.
- RxStrategies: 340B TPA and consulting firm supporting covered entities with compliance and contract pharmacy management, closely mirroring MediraRx's service model.
- CaptureRx: 340B contract pharmacy and TPA administrator historically serving FQHCs and clinics, comparable to MediraRx's covered-entity focus.
- SUNRx (McKesson): 340B contract pharmacy administration and TPA services provider serving safety-net entities, a direct competitor in the 340B administration niche.
- Sentry Data Systems: Offers 340B compliance, analytics, and management software for hospitals and health systems, competing directly in 340B program administration.
- Verity Solutions: Provides 340B split-billing software and TPA services to covered entities, directly overlapping with MediraRx's 340B management platform and administration offering.
Others
- Apexus: The HRSA-designated 340B Prime Vendor providing pricing, education, and resources for the program; an ecosystem enabler adjacent to MediraRx rather than a direct competitor.
Emerging players
- 340B Technologies: Offers 340B split-billing and TPA software with a niche focus, overlapping MediraRx's platform for smaller covered entities.
Broad incumbents
- Wellpartner (CVS Health): CVS-owned 340B contract pharmacy administrator serving covered entities, overlapping with MediraRx's TPA and contract-pharmacy management services.
- Macro Helix (McKesson): McKesson's 340B Architect platform manages split billing and compliance at scale for large health systems, an established incumbent in the same 340B software category.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
MediraRx social profiles
Digital presenceMediraRx compliance and trust
Trust signalCompliance1 record
MediraRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
MediraRx leadership team
Management profileNumber of profiles
Profiles1 record
MediraRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MediraRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MediraRx
What does MediraRx do?
MediraRx designs, implements, and manages 340B Drug Pricing Programs for safety net healthcare providers (covered entities) such as hospitals, health centers, HIV/AIDS clinics, STD clinics, and behavioral health organizations. The company combines a cloud-based 340B compliance and management software platform with third-party administrator (TPA) services, consulting, pharmacy network development, and reporting, enabling clients to maintain regulatory compliance, prevent duplicate discounts, and capture savings on outpatient drug purchases.
Is MediraRx a public or private company?
MediraRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MediraRx founded?
MediraRx was founded in 2009. It employs 1 to 10 people.
Where is MediraRx based?
MediraRx is headquartered in New York, United States, in the North America region.
How does MediraRx make money?
One revenue line is on record: 340B Program Administration Services.
Who are MediraRx's main competitors?
Direct peers on record are Nuvem, RxStrategies, CaptureRx, SUNRx (McKesson), Sentry Data Systems and Verity Solutions. Apexus is listed as an others. 340B Technologies is listed as an emerging player. Broad incumbents are Wellpartner (CVS Health) and Macro Helix (McKesson).
Does MediraRx have an API?
No public API is recorded for MediraRx.
What industry is MediraRx in?
MediraRx's product category is 340B Program Management Software. Its primary akta.pro industry code is HLACAKAN, Medication Pricing, Copay Assistance & Patient Financial Support Tools. Its NAICS code is 524292 and its SIC code is 7372.